TotalMarketCap

Vanda Pharmaceuticals

VNDANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$217.691 M

$3.60 -7.22%

Close of 6 Nov 2026

As of 6 Nov 2026, Vanda Pharmaceuticals (VNDA) has a market capitalization of $217.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$216.1M

#2245 by revenue

Earnings

-$220.5M

Loss-making

Shares outstanding

60,469,687

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #238Korro BioKRRO$219.3M
  2. #239ImmuneeringIMRX$217.9M
  3. #240Vanda PharmaceuticalsVNDA$217.7M
  4. #241Greenwich LifeSciencesGLSI$214.6M
  5. #242Siga TechnologiesSIGA$213.0M

What if Vanda Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$466,959.15

Per share 129,711× higher

Bitcoin $1.53T

$25,266.35

Per share 7,018× higher

Apple $5.02T

$82,947.06

Per share 23,041× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Vanda Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.